Open Access
| Issue |
BIO Web Conf.
Volume 111, 2024
2024 6th International Conference on Biotechnology and Biomedicine (ICBB 2024)
|
|
|---|---|---|
| Article Number | 03021 | |
| Number of page(s) | 4 | |
| Section | Medical Testing and Health Technology Integration | |
| DOI | https://doi.org/10.1051/bioconf/202411103021 | |
| Published online | 31 May 2024 | |
- Colella P, Ronzitti G, Mingozzi F. Emerging Issues in AAV-Mediated In Vivo Gene Therapy. Mol Ther Methods Clin Dev, 2017;8:87–104. [Google Scholar]
- Berns K.I., Daya S. Gene Therapy Using Adeno-Associated Virus Vectors [J]. Clin Microbiol Rev, 2008, 21(4):583–593. [CrossRef] [PubMed] [Google Scholar]
- Wang D, Tai P.W.L., Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov, 2019;18(5):358–378. [CrossRef] [PubMed] [Google Scholar]
- Preclinical Assessment of Investigational Cellular and Gene Therapy Products [S]. Food And Drug Administration, 2013. [Google Scholar]
- Consideration for the Design of Early-Phase Clinical Trials of Cellular and Gene Therapy Products [S]. Food and Drug administration, 2015. [Google Scholar]
- Design and Analysis of Shedding Studies for Virus or Bacteria-Based Gene Therapy and Oncolytic Products [S]. Food And Drug Administration, 2015. [Google Scholar]
- Guideline on the Quality, Non-clinical and Clinical Aspects of Gene Therapy Medicinal Products [S]. European Medicines Agency, 2015. [Google Scholar]
- Christopher J.L., Joohee H, Tatyana G, et al. Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic cancer [J]. Surgery, 2015, 157 (5): 888–898. [CrossRef] [PubMed] [Google Scholar]
- Kazuhide I, Yasuhiro U, Masahiro U, et al. Importance of cynomolgus monkeys in development of monoclonal antibody drugs [J]. Drug Metab Pharmacok, 2019, 34: 55–63. [CrossRef] [Google Scholar]
- Schirmacher V. Oncolytic Newcastle disease virus as prospective anti-cancer therapy. A biologic agenet with potential to breat therapy resistance [J]. Expert Opin Biol Ther, 2015, 15 (12): 1757–1771. [CrossRef] [PubMed] [Google Scholar]
- Nguyen G.N., Everett J.K., Kafle S, Roche A.M., Raymond H.E., Leiby J, Wood C, Assenmacher C.A., Merricks E.P., Long C.T., Kazazian H.H., Nichols T.C., Bushman F.D., Sabatino D.E.. A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells. Nat Biotechnol. 2021 Jan;39(1):47–55. doi: 10.1038/s41587-020-0741-7. Epub 2020 Nov 16. PMID: 33199875; PMCID: PMC7855056. [CrossRef] [PubMed] [Google Scholar]
- Sabatino D.E., Bushman F.D., Chandler R.J., Crystal R.G., Davidson B.L., Dolmetsch R, Eggan K.C., Gao G, Gil-Farina I, Kay M.A., McCarty D.M., Montini E, Ndu A, Yuan J; American Society of Gene and Cell Therapy (ASGCT) Working Group on AAV Integration. Evaluating the state of the science for adenoassociated virus integration: An integrated perspective. Mol Ther. 2022 Aug 3;30(8):2646–2663. doi: 10.1016/j.ymthe.2022.06.004. Epub 2022 Jun 10. PMID: 35690906; PMCID: PMC9372310. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.